Divis Laboratories Gains 2.59%: 5 Key Factors Driving the Week’s Momentum

35 minutes ago
share
Share Via
Divis Laboratories Ltd delivered a solid weekly gain of 2.59%, closing at Rs.9,610 on 25 September 2026, outperforming the Sensex which declined 0.76% over the same period. The stock demonstrated resilience amid mixed technical signals, a rating downgrade to Hold, and heightened derivatives market activity, reflecting a complex but cautiously optimistic market sentiment.

Key Events This Week

21 Sep: Stock opens strong at Rs.9,432 (+0.69%) alongside Sensex gains

22 Sep: Price dips to Rs.9,344 (-0.93%) amid technical caution

23 Sep: Mojo Grade downgraded to Hold; stock rebounds to Rs.9,596.75 (+2.70%)

24 Sep: Sharp surge in open interest and new 52-week high at Rs.9,626.5

25 Sep: Open interest rises further despite slight price dip to Rs.9,610 (-0.03%)

Week Open
Rs.9,367
Week Close
Rs.9,610
+2.59%
Week High
Rs.9,626.5
vs Sensex
+3.35%

21 September: Positive Start Amid Broader Market Gains

Divis Laboratories began the week on a positive note, closing at Rs.9,432, up 0.69% from the previous Friday’s close of Rs.9,367. This outpaced the Sensex’s 0.46% gain to 35,787.64, signalling early investor confidence. The stock’s volume of 10,421 shares supported this upward move, reflecting steady demand. The broader market optimism provided a favourable backdrop for Divis, which maintained its position comfortably above key moving averages.

22 September: Technical Caution Weighs on Price

On 22 September, the stock retreated to Rs.9,344, a decline of 0.93%, underperforming the Sensex which fell 0.32% to 35,672.04. This dip coincided with emerging technical caution as momentum oscillators began signalling overbought conditions. The reduced volume of 5,558 shares suggested a temporary pullback rather than a sustained sell-off. Market participants appeared to digest recent gains, with the stock hovering near its recent highs but facing resistance.

23 September: Mojo Grade Downgrade and Technical Momentum Shift

Wednesday marked a pivotal day as MarketsMOJO downgraded Divis Laboratories from Buy to Hold, citing mixed technical and valuation signals. Despite this, the stock surged 2.70% to close at Rs.9,596.75, outperforming the Sensex’s 0.56% gain. The upgrade in technical momentum from mildly bullish to bullish was supported by strong MACD readings, though bearish RSI readings indicated caution. The stock traded within a range of Rs.9,305.95 to Rs.9,621.25, inching closer to its 52-week high of Rs.10,000.00. Institutional investors’ confidence remained evident with a significant 39.58% stakeholding, underscoring the company’s fundamental strength despite the rating adjustment.

Our latest weekly pick is live! This Large Cap from Diamond & Gold Jewellery comes with clear entry and exit targets. See the detailed report with target price now!

  • - Clear entry/exit targets
  • - Target price revealed
  • - Detailed report available

View Target Price Report →

24 September: Surge in Open Interest and New 52-Week High

On 24 September, Divis Laboratories hit a fresh 52-week high of Rs.9,626.5, closing at Rs.9,613, a modest gain of 0.17%. The day was marked by a sharp 17.9% increase in open interest to 96,967 contracts in the derivatives segment, accompanied by a robust trading volume of 1,57,107 contracts. The futures segment alone accounted for a notional value of approximately ₹2,15,998 lakhs, while options contributed significantly more, reflecting strong market engagement. Despite the bullish price action and technical momentum, delivery volumes declined by 18.61%, suggesting some profit booking or cautious participation by long-term investors. The stock remained above all key moving averages, reinforcing its bullish technical stance amid mixed volume signals.

25 September: Continued Open Interest Growth Amid Slight Price Dip

The week closed on a nuanced note with Divis Laboratories’ stock price marginally down 0.03% to Rs.9,610, while the Sensex gained 0.18%. Open interest surged again by 15.33% to 98,290 contracts, with futures volume at 73,282 contracts and a combined futures and options value of approximately ₹17,32,35 lakhs. Delivery volumes increased by 42.73% to 4.47 lakh shares, indicating renewed conviction among long-term investors. The stock traded within a narrow range, just 1.64% shy of its 52-week high, maintaining its position above all major moving averages. The slight price dip amid rising derivatives activity suggests mixed market positioning, with traders balancing bullish bets against cautious hedging amid the recent Hold rating.

Holding Divis Laboratories Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!

  • - Peer comparison ready
  • - Superior options identified
  • - Cross market-cap analysis

Switch to Better Options →

Daily Price Comparison: Divis Laboratories vs Sensex

Date Stock Price Day Change Sensex Day Change
2026-09-21 Rs.9,432.00 +0.69% 35,787.64 +0.46%
2026-09-22 Rs.9,344.00 -0.93% 35,672.04 -0.32%
2026-09-23 Rs.9,596.75 +2.70% 35,870.78 +0.56%
2026-09-24 Rs.9,613.00 +0.17% 35,291.38 -1.62%
2026-09-25 Rs.9,610.00 -0.03% 35,353.29 +0.18%

Key Takeaways

Strong Relative Performance: Divis Laboratories outperformed the Sensex by 3.35% over the week, reflecting robust demand despite broader market weakness.

Rating Downgrade to Hold: The downgrade on 22 September signals caution due to stretched valuations and mixed technical indicators, tempering near-term enthusiasm.

Technical Momentum Mixed but Predominantly Bullish: MACD and moving averages support an upward trend, while bearish RSI and mixed volume indicators suggest potential short-term consolidation.

Derivatives Market Activity: Sharp increases in open interest and volume highlight active positioning and heightened market interest, though delivery volume fluctuations indicate varied investor participation.

Valuation and Growth Concerns: Despite strong fundamentals and consistent profitability, slower long-term growth and elevated price-to-book and PEG ratios warrant a cautious stance.

Conclusion

Divis Laboratories Ltd demonstrated resilience and relative strength during the week ending 25 September 2026, gaining 2.59% against a declining Sensex. The stock’s performance was shaped by a complex interplay of factors including a rating downgrade to Hold, mixed but predominantly bullish technical signals, and significant derivatives market activity. While the company’s fundamentals remain solid with strong management efficiency and consistent quarterly profitability, valuation premiums and slowing long-term growth temper the outlook. The surge in open interest and volume in derivatives markets suggests active positioning and anticipation of future price movements, though delivery volume trends indicate some caution among long-term investors. Overall, the stock’s technical and fundamental profile supports a measured approach, balancing optimism for continued momentum with vigilance for potential consolidation or volatility in the near term.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News